LOADING

Type to search

Brainstorm Cell Therapeutics Names Setboun Chief Operating Officer

BioTech

Brainstorm Cell Therapeutics Names Setboun Chief Operating Officer

Share
brainstorm-cell-therapeutics-names-setboun-chief-operating-officer

Xconomy
New York
— 

David Setboun has been appointed executive vice president and chief operating officer of Brainstorm Cell Therapeutics (NASDAQ: BCLI). He is joining New York-based Brainstorm from Life Biosciences, where he was vice president of corporate development, strategy and business. Setboun’s experience also includes positions at Biogen (NASDAQ: BIIB), AstraZeneca (NYSE: AZN), and Eli Lilly (NYSE: LLY). Brainstorm’s lead program,  NurOwn, is in Phase 3 testing in amyotrophic lateral sclerosis and in Phase 2 testing in progressive multiple sclerosis.

Frank Vinluan is an Xconomy editor based in Research Triangle Park. You can reach him at fvinluan@xconomy.com. Follow @frankvinluan

Trending on Xconomy

Tags:

You Might also Like

Leave a Comment

Your email address will not be published. Required fields are marked *